成立于2011年9月
北京锤特生物科技有限公司创建于2011年9月，注册资金1654.0063万人民币，是专注于恶性肿瘤诊断和治疗的高科技生物技术公司。公司位于北京高新技术产业园--亦庄汇龙森产业园区内，依托生物医药基地良好的环境和政策，建有符合GMP、GLP国际标准认证的实验室。
高质量的产品
公司产品主要包括肿瘤诊断试剂盒、抗肿瘤新药、肿瘤免疫治疗产品及与其相关的辅助产品。
富有经验的管理团队
公司拥有一支优秀、结构合理、高效、富有经验的管理团队；拥有一群团结勤奋、生物医药相关工作经历丰富的员工。创建伊始，就以中国广大肿瘤患者为核心服务对象，把产品的技术创新放在首位，将严谨、踏实的管理作为企业的生存之道。
Beijing Bio-Targeting Therapeutics Technology Co., Ltd (BioTTT) is a biotech companydedicated to the discovery and development of innovative, best-in-class,targeted and immuno-oncology drugs that address severe unmet medical needs inthe field of cancer diagnosis and treatment. BioTTT was founded in September 2011 and is situated in Beijing economicand technological development zone-Huilongsen Science Park. Taking advantage ofthe great environment and the favorable policies of the government, BioTTT hasbuilt a laboratory compliant with the international standard certification ofGMP and GLP. A number of products with intellectual property protection arebeing actively investigated at various stages, including an in vitro diagnosiskit for circulating viable tumor cells and an innovative anti-cancer drug(BioTTT001). Other businesses are provision of CTC culture and services ofbiotechnologies.
The company strategy is to build an integrated biotech company that discovers, develops andcommercializes innovative diagnosis and therapy for cancer both independentlyand in collaboration with top academic institutions and other partners.
BioTTT has a highly motivated team focused on the successful execution of ourobjectives and strategy. We have also tapped the talents of a number ofworld-known overseas (UK, US, etc.) and domestic experts in the biotech andcancer research field. We are striving to develop and advance the innovativetherapies for patients who are battling with cancer.
关闭返回